ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 230 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q2 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $842,977 | -93.6% | 125,630 | -61.5% | 0.00% | -93.8% |
Q1 2021 | $13,150,000 | -52.8% | 326,635 | -30.7% | 0.02% | -56.8% |
Q4 2020 | $27,872,000 | +4.3% | 471,366 | -14.3% | 0.04% | -14.0% |
Q3 2020 | $26,733,000 | +883.2% | 549,722 | +878.2% | 0.04% | +760.0% |
Q2 2020 | $2,719,000 | – | 56,196 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blue Water Life Science Advisors, LP | 1,687,665 | $5,417,405 | 5.10% |
Rubric Capital Management LP | 10,500,000 | $33,705,000 | 1.00% |
Triatomic Management LP | 98,555 | $316,362 | 0.59% |
Pier Capital, LLC | 1,103,441 | $3,542,046 | 0.49% |
Newtyn Management, LLC | 623,690 | $2,002,045 | 0.40% |
VIKING GLOBAL INVESTORS LP | 29,993,708 | $96,279,803 | 0.36% |
Matrix Capital Management Company, LP | 11,572,590 | $37,148,014 | 0.34% |
Tejara Capital Ltd | 269,014 | $863,535 | 0.32% |
Aristotle Atlantic Partners, LLC | 2,992,563 | $9,606,127 | 0.31% |
DDD Partners, LLC | 739,739 | $2,374,562 | 0.29% |